Aim:To examine the protective effect of apigenin on alcohol-induced liver injury and investigate the potential mechanisms.Methods:In vivo,Kunming male mice were randomly divided into the control group,model group,apigenin 150 and 300 mg/kg groups,and gluthion 240 mg/kg group.The experimental mice were given 56°Redstar erguotou wine or simultaneously given apigenin150-300 mg/kg by gavage for 30 days.Finally,all the mice were sacrificed,the levels of serum alanine aminotransferase(ALT)and aspartate aminotransferase(AST),hepatic reduced glutathione(GSH),glutathione reductase(GR),glutathione peroxidase(GSH-PX),glutathione-S-transferase(GST),malondialdehyde(MDA),alcohol dehydrogenase(ADH),acetaldehyde dehydrogenase(ALDH),and tumor necrosis factor-alpha(TNF-α)were determined.The coefficient of liver weight was calculated and the hepatic histopathological changes were examined under a light microscope.The expressions of hepatic peroxisome proliferator-activated receptor(PPAR)α/γ,sterol regulatory element binding protein-1c(SREBP-1c),fatty acid synthase(FAS),diacylglycerol acyltransferase(DGAT),carnitine palmitoyltransferase-1(CPT-1),cytochrome P450 2E1(CYP2E1),and nuclear factor kappa B(NF-κB)proteins were determined by Western Blot methods,respectively.In vitro,the rat BRL hepatocytes were used to observe the effects of apigenin on ethanol-or its toxic metabolite acetaldehyde-and hydrogen peroxide(H2O2)-induced hepatocellular injury as well as lipopolysaccharide(LPS)-induced inflammatory cytokine production.In the acetaldehyde-treated cells,the levels of the supernatant ALT and ALDH were determined.In the H2O2-treated cells,the levels of the supernatant MDA and superoxide dismutase(SOD)were determined.In the ethanol-treated cells,CYP2E1inducer isoniazid-treated cells,ethanol plus isoniazid-treated cells,and ethanol plus GR inhibitor carmustine-treated cells,the levels of the supernatant ALT and MDA as well as the intracellular GSH,GR,GSH-PX,GST,and CYP2E1 were determined.In the LPS-treated cells,the levels of the supernatant TNF-αand interleukin-6(IL-6)as well as the expressions of the intracellular NF-κB and IκB-αproteins were determined.Results:In vivo,the results showed that after treatment with apigenin150-300 mg/kg30 days,the coefficient of liver weight and serum AST level were decreased,especially in the 300 mg/kg group(p<0.05 or p<0.01).Also,the levels of hepatic ADH and TNF-αwere decreased(p<0.05 or p<0.01).Inversely,the levels of hepatic GR,GSH-PX,GST,and ALDH were increased(p<0.05 or p<0.01).Furthermore,the histological evaluation of liver specimens demonstrated that the degree of hepatic steatosis in apigenin-treated groups was ameliorated.The Western Blot assays showed that apigenin could significantly up-regulate the expressions of hepatic PPARα/γand CPT-1A proteins(p<0.01),and down-regulate the expressions of hepatic SREBP-1c,FAS,DGAT,CYP2E1,and NF-κB proteins(p<0.01).In vitro,the results showed that following pretreatment of cells with apigenin,the levels of supernatant ALT,MDA,TNF-α,and IL-6 as well as the expressions of hepatocellular CYP2E1 and NF-κB proteins were significantly reduced(p<0.05 or p<0.01),while the levels of hepatocellular GR,GSH-PX,SOD,and ALDH as well as IκB-αprotein expression were significantly increased(p<0.05 or p<0.01).Conclusion:The present results demonstrated that apigenin might exert a protective effect on alcohol-induced liver injury,and its mechanisms might be related to the acceleration of ethanol metabolite acetaldehyde degradation,improvement of PPARα-mediated lipid metabolism pathway,and inhibition of CYP2E1 expression and enhancement of antioxidant ability.The latter and PPARγmight synergically decrease the ROS-mediated NF-κB activation and inflammatory cytokine production. |